Pmv Pharmaceuticalsinc Stock Beneish M Score
| PMVP Stock | USD 1.73 0.12 7.45% |
Pmv | Beneish M Score |
At this time, it appears that Pmv PharmaceuticalsInc is an unlikely manipulator. The earnings manipulation may begin if Pmv PharmaceuticalsI's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Pmv PharmaceuticalsI executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Pmv PharmaceuticalsI's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-5.33
Beneish M Score - Unlikely Manipulator
Pmv PharmaceuticalsI Beneish M-Score Indicator Trends
The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Pmv PharmaceuticalsI's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 254.1 M | 252.2 M |
|
| |||||
| Total Current Assets | 235.5 M | 207.4 M |
|
| |||||
| Non Current Assets Total | 47 M | 44.7 M |
|
| |||||
| Property Plant Equipment | 13.2 M | 12.6 M |
|
| |||||
| Depreciation And Amortization | 1.3 M | 1.3 M |
|
| |||||
| Selling General Administrative | 23 K | 24.2 K |
|
| |||||
| Total Current Liabilities | 9.2 M | 14 M |
|
| |||||
| Non Current Liabilities Total | 11.8 M | 12.4 M |
|
| |||||
| Short Term Debt | 653.8 K | 852 K |
|
|
Pmv PharmaceuticalsInc Beneish M-Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Pmv PharmaceuticalsI's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Pmv PharmaceuticalsI in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Pmv PharmaceuticalsI's degree of accounting gimmicks and manipulations.
Click cells to compare fundamentals
About Pmv PharmaceuticalsI Beneish M Score
M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.
Depreciation And Amortization |
|
Pmv PharmaceuticalsI Earnings Manipulation Drivers
Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Pmv PharmaceuticalsI. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 103.0M | 365.5M | 331.6M | 270.3M | 252.2M | 254.1M | |
| Total Current Assets | 102.1M | 364.8M | 301.3M | 247.0M | 207.4M | 235.5M | |
| Non Current Assets Total | 940K | 770K | 30.3M | 23.3M | 44.7M | 47.0M | |
| Property Plant Equipment | 739K | 569K | 13.2M | 11.0M | 12.6M | 13.2M | |
| Depreciation And Amortization | 388K | 318K | 307K | 315K | 1.3M | 1.3M | |
| Selling General Administrative | 5.9M | 11.0M | 21.8M | 25.1M | 24.2K | 23.0K | |
| Total Current Liabilities | 4.5M | 6.4M | 12.2M | 10.8M | 14.0M | 9.2M | |
| Non Current Liabilities Total | 169.0M | 1.6M | 10.8M | 13.4M | 12.4M | 11.8M | |
| Net Debt | 95.7M | (361.4M) | (161.3M) | (94.3M) | (25.2M) | (26.5M) | |
| Operating Income | (26.6M) | (34.9M) | (58.3M) | (77.0M) | (80.1M) | (76.1M) | |
| Total Cash From Operating Activities | (22.1M) | (32.7M) | (46.6M) | (63.8M) | (55.7M) | (58.4M) | |
| Investments | 3.3M | 27.9M | (142.2M) | 6.6M | (24.7M) | (26.0M) | |
| Short Term Investments | 28.2M | 0.0 | 124.7M | 132.8M | 165.4M | 88.5M |
About Pmv PharmaceuticalsI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pmv PharmaceuticalsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pmv PharmaceuticalsI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pmv PharmaceuticalsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pmv PharmaceuticalsI in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pmv PharmaceuticalsI's short interest history, or implied volatility extrapolated from Pmv PharmaceuticalsI options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pmv PharmaceuticalsInc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Pmv PharmaceuticalsI Piotroski F Score and Pmv PharmaceuticalsI Altman Z Score analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Pmv Stock analysis
When running Pmv PharmaceuticalsI's price analysis, check to measure Pmv PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv PharmaceuticalsI is operating at the current time. Most of Pmv PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Pmv PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Pmv PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Pmv PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pmv PharmaceuticalsI. If investors know Pmv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pmv PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.44) | Return On Assets (0.19) | Return On Equity (0.29) |
The market value of Pmv PharmaceuticalsInc is measured differently than its book value, which is the value of Pmv that is recorded on the company's balance sheet. Investors also form their own opinion of Pmv PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Pmv PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pmv PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Pmv PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pmv PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pmv PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pmv PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.